Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schulz

Showing results (801-810 of 835) with videos related to

Pageof 84
Sort By:
Antimicrobial Agents and Chemotherapy|February 6, 2024
Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targetsSibylle Haid, Alina Matthaei, Melina Winkler, et al.
Journal of Virology|November 1, 2019
Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated VirolysisHans Prochnow, Katharina Rox, N V Suryanarayana Birudukota, et al.
Plos Pathogens|May 26, 2017
Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migrationVíctor González-Motos, Carina Jürgens, Birgit Ritter, et al.
Journal of Medical Virology|July 24, 2008
Genotypic analysis of two hypervariable human cytomegalovirus genesAmanda J Bradley, Ida J Kovács, Derek Gatherer, et al.
Cell Host & Microbe|January 1, 2022
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizersKanika Vanshylla, Chengcheng Fan, Marie Wunsch, et al.
Journal of Virology|November 4, 2024
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutationSaskia C Stein, Guido Hansen, George Ssebyatika, et al.
Leukemia|January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classificationK Nachtkamp, C Strupp, M Vukelja, et al.
Journal of Clinical Epidemiology|November 25, 2022
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issuesYing Wang, Maryam Ghadimi, Qi Wang, et al.
Molecular Cell|February 22, 2023
Evolutionary origins and interactomes of human, young microproteins and small peptides translated from short open reading framesClara-L Sandmann, Jana F Schulz, Jorge Ruiz-Orera, et al.
Cell Host & Microbe|July 14, 2017
Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene ExpressionDonal McHugh, Nicole Caduff, Mario Henrique M Barros, et al.
Pageof 84

Showing results (801-810 of 835) with videos related to

Sort By:
Pageof 84
Antimicrobial Agents and Chemotherapy|February 6, 2024
Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targetsSibylle Haid, Alina Matthaei, Melina Winkler, et al.
Journal of Virology|November 1, 2019
Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated VirolysisHans Prochnow, Katharina Rox, N V Suryanarayana Birudukota, et al.
Plos Pathogens|May 26, 2017
Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migrationVíctor González-Motos, Carina Jürgens, Birgit Ritter, et al.
Journal of Medical Virology|July 24, 2008
Genotypic analysis of two hypervariable human cytomegalovirus genesAmanda J Bradley, Ida J Kovács, Derek Gatherer, et al.
Cell Host & Microbe|January 1, 2022
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizersKanika Vanshylla, Chengcheng Fan, Marie Wunsch, et al.
Journal of Virology|November 4, 2024
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutationSaskia C Stein, Guido Hansen, George Ssebyatika, et al.
Leukemia|January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classificationK Nachtkamp, C Strupp, M Vukelja, et al.
Journal of Clinical Epidemiology|November 25, 2022
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issuesYing Wang, Maryam Ghadimi, Qi Wang, et al.
Molecular Cell|February 22, 2023
Evolutionary origins and interactomes of human, young microproteins and small peptides translated from short open reading framesClara-L Sandmann, Jana F Schulz, Jorge Ruiz-Orera, et al.
Cell Host & Microbe|July 14, 2017
Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene ExpressionDonal McHugh, Nicole Caduff, Mario Henrique M Barros, et al.
Pageof 84